
ASEAN-EU HEALTH SUMMIT 2021
The EU-ASEAN Business Council’s flagship ASEAN-EU Summit event is back for its 9th run this year, to be held in Singapore on 15 September 2021. With circumstances posed by the COVID-19 pandemic and as we integrate to the new normal, both in the region and globally, this year’s edition will revolve around the highly relevant theme of health-related issues. It follows on from the exceedingly successful hybrid virtual/physical model (the Council’s first) held last year, graced by Mr Chan Chun Sing, Singapore’s Minister of Trade and Industry, ASEAN Ministers, Ambassadors and prominent business leaders who spoke at the event attended by high-level delegates virtually and physically.
Similar to last year’s approach, the ASEAN-EU Health Summit will be a hybrid virtual/physical event to keep in line with COVID-19 restrictions and social distancing measures, providing guests the option of attending the event virtually.
The ASEAN-EU Business Summit was founded in 2011 in Indonesia and has since developed into an established meeting point in ASEAN with several hundred delegates attending each event. With the focus this year on transformative solutions in healthcare and emerging trends in the industry, The Summit will serve as a platform for business connections, bringing together senior leaders and policy makers in ASEAN’s healthcare industry.
Date: 15 September 2021
Venue: Stamford Ballroom, Raffles City Convention Centre
Time: 12.30pm (Registration) to 6.30pm
The EU-ABC is pleased to extend this event on a complimentary basis
• As seats are limited, priority to attend the event onsite will be given to EU-ABC members and representatives of the diplomatic corps.
• Members and guests have the option of attending the event virtually.
• Register for the event via the registration button
FEATURING

H.E. Ong Ye Kung
Minister for Health, Singapore

H.E. Budi Gunadi Sadikin
Minister of Health, Indonesia
Susanne Andreae
Head of Health and
Healthcare Industry,
World Economic Forum

Isabelle Deschamps
Head of Global Vaccines
Public Affairs, Sanofi

HIGHLIGHT
Panel 1: Unlocking the ASEAN Longevity Dividend Through Cost-Effective Prevention
It’s not news that our populations are rapidly ageing, a blessing of the 20th century extension of life expectancy that places demographic pressures on our 21st century models. While ASEAN still lags behind average life expectancy with some room to catch up, the proportion of population officially labelled “aged” in the region has doubled and is on a trajectory to reach nearly one-fifth of total peoples by 2035.
ASEAN will simply miss out on its demographic dividend period, unless it makes dramatic changes to the approach toward population. Known as the longevity dividend, there is opportunity to act now so as to harness the evolving demographic patterns, especially through increased resource utilisation toward proven prevention-style interventions. In this session we focus specifically on life-course immunisation as an available tool for ASEAN governments to leverage.
Expert Panel: Pandemic Preparedness & Lessons for ASEAN and Beyond
The global response to COVID-19 has called both global and regional pandemic preparedness into question. Moving forward, there is a growing need to build new forms of collaboration and partnerships with key stakeholders. There is no question that there has been an unprecedented speed to develop tests, treatments and vaccines to keep people across the globe safe. But there are still questions regarding Southeast Asia’s collective ability to ensure preparedness for future pandemics and challenges to come.
Panel 3: Sustainable Healthcare Financing in ASEAN and Asia Pacific
In November 2019, the Council kicked off a new initiative at the ASEAN Secretariat Digital Health Summit with an ambition to discover more creative financing mechanisms to achieve our Universal Health Coverage (UHC) ambitions in the region. We presented these findings in a landmark report in March 2020, with subsequent bespoke briefings to ASEAN Ministries over the past year. The topic became particularly relevant during the pandemic, when a “do more with less” mentality ruled health and wider social investment priorities.
Now in 2021, the Council’s sustainable healthcare financing concept is officially a World Economic Forum program. We’ve conducted additional research across ASEAN, as well as involving other key regional markets such as India, China, and Japan. There is something to teach and something to learn across key themes such as immunization, diabetes management, and rare diseases, which are simultaneously our greatest healthcare financing challenges and opportunities for economic development.
Breakout Sessions
(A) Tackling Substandard and Falsified Medicines in ASEAN
Counterfeit and falsified drugs can have a serious impact upon human health. These drugs have adverse effects on pharmaceutical companies’ profits and branding. More importantly, falsified medicines threaten human lives, by causing further illness, disability, resistance to authentic medicines, and even death Tackling counterfeit drugs is therefore an important issue which companies and governments alike are looking to combat in Southeast Asia.
(B) Shaping Society and ASEAN’s Modern Economy through Digital Health Solutions
Digital health solutions use platforms such as mobile devices, enabling the wider population of ASEAN to gain access to healthcare. Although it provides novel opportunities, digital health solutions have also introduced a new set of regulatory challenges for the decision makers in ASEAN. New technological developments are responding by increasingly blurring the boundaries between the physical, biological, and digital worlds. The digital revolution has the potential to benefit the health of all, but it can also lead to new ethical challenges. Now, more than ever, there is a growing need for convergence of digital health regulations across Southeast Asia.
(C) Transforming Self Care: Role of E-Pharmacies & Improved Access to Medicines
It is no secret that a healthy population is a productive population, which impacts overall tax contribution and human capital development. However, the converse is also true and should be avoided. A possible solution for ASEAN moving forward would be to prioritise Self-Care where citizens can manage their own wellness. This does not only frees up strained healthcare systems in ASEAN but also encourage individuals to hold a level of responsibility for health outcomes.
OUR SPEAKERS

H.E. Ong Ye Kung
Minister for Health, Singapore

H.E. Budi Gunadi Sadikin
Minister of Health, Indonesia
Dr. Janil Puthucheary
Senior Minister of State
Ministry of Communications and Information & Ministry of Health
Singapore

Director-General Sandra Gallina
Directorate-General for Health and Food Safety, European Commission

H.E. Dato Lim Jock Hoi
Secretary-General of ASEAN

H.E. Kung Phoak
Deputy Secretary-General of ASEAN for ASEAN Socio-Cultural Community

Professor Peter Piot
Special advisor to
President Ursula von der Leyen on the response to the coronavirus and COVID-19 & Director of the School and Handa Professor of Global Health

Alexis Serlin
Head ASIA Cluster,
Novartis Pharma, Novartis Asia Pacific Pharmaceuticals
Jakob Sebastian Angele
CEO APAC, foodpanda

H.E. Hok Kimcheng
Director General for Health, Cambodia


Janice Chia
Founder & Managing Director, Aging Asia

Chris Hardesty
Director, Healthcare & Life Sciences, KPMG
Michael Hodin
CEO, Global Coalition on Ageing

Ada Wong
Asia Public Affairs Lead, Sanofi

Otelli Edwards
Presenter, CNA

Professor Peter Piot
Special advisor to
President Ursula von der Leyen on the response to the coronavirus and COVID-19 & Director of the School and Handa Professor of Global Health

Dr Jeremy Lim
Partner, Leading Public Health Expert,
National University of Singapore

Nathanael Faibis
CEO, Alodokter


Andrew Wong
Chief Health Officer, Asia & Africa,
Prudential Corporation Asia

Thiam Hwa Lim
Healthcare Director, SEA Industry Business Architect (Healthcare), SAP
Dr Noppadon Adjimatera
ASEAN Health Policy and Scientific Affairs Director, Reckitt

Alvin So
Head of Commercial Operations, Bayer Consumer Health Division ASEAN


Lovy Beh
President, Malaysian Community Pharmacy Guild

Isabelle Deschamps
Head of Global Vaccines
Public Affairs, Sanofi
Susanne Andreae PhD
Head of Health and Healthcare Industry,
World Economic Forum

Eduardo Banzon
Principal Health Specialist, Southeast Asia Regional Department,
Asian Development Bank


Franck Perraudin
Head of Global Health Partnerships and Alliances, Sanofi

Dr Hak Hong Soo
Regional Head of Health, Asia, Generali

Chris Humphrey
Executive Director, EU-ASEAN Business Council

Roberta Sarno
Manager, Digital Health Committee, APACMed

Ramesh Raj Kishore
Regional Director, Asia Pacific, Pharmaceutical Security Institute

Stephen D Dunn
Head of Product Security Investigations, APAC, Sanofi
Saleha Abd Rahman
Deputy Director, Pharmacy Forensic Section, Pharmacy Enforcement Division, Pharmaceutical Services Programme, Ministry of Health Malaysia

Brett Marshall
Corporate Head of Quality Assurance, Zuellig Pharma

SCHEDULE
For full programme, click here
Get in Touch
EU-ASEAN Business Council
Suite 29, Level 30, Six Battery Road,
Singapore, 049909
http://eu-asean.eu | info@eu-asean.eu
+65-6725-6545
Form has been submitted.
The EU-ASEAN Business Council (EU-ABC) is the sole voice for European Business within the ASEAN region, formally recognised as such by the European Commission and the ASEAN Secretariat. Established to help promote the interests of European businesses operating within ASEAN and to advocate for changes in trade and investment policies and regulations, the EU-ABC raises the profile of European businesses in the region through formal events and high-profile dialogues.

















